Versant Capital Management, Inc Cytokinetics Inc Transaction History

Versant Capital Management, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$19.79 - $26.99 $8,292 - $11,308	-419 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$18.57 - $25.68 $3,806 - $5,264	-205 Reduced 32.85%	419 $10,000
Q4 2020 Feb 08, 2021	SELL	$15.26 - $28.61 $595 - $1,115	-39 Reduced 5.88%	624 $12,000
Q2 2020 Jul 16, 2020	BUY	$11.15 - $24.64 $3,501 - $7,736	314 Added 89.97%	663 $15,000
Q1 2020 Apr 17, 2020	BUY	$8.75 - $16.3 $105 - $195	12 Added 3.56%	349 $4,000
Q2 2019 Jul 16, 2019	BUY	$7.95 - $11.25 $2,035 - $2,880	256 Added 316.05%	337 $3,000
Q1 2019 Apr 23, 2019	BUY	$5.95 - $10.19 $481 - $825	81 New	81 $0
Q1 2019 Apr 23, 2019	SELL	$5.95 - $10.19 $481 - $825	-81 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$6.4 - $9.85 $518 - $797	81 New	81 $0
Q2 2018 Jul 06, 2018	SELL	$6.9 - $9.9 $144 - $207	-21 Closed	0 $0
Q1 2018 Apr 19, 2018	BUY	$7.2 - $10.05 $151 - $211	21 New	21 $0

407

125M

4.52M

2.28M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.15B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.